COST-EFFECTIVENESS OF VACCINATING CHILDREN AGED 2-17 YEARS WITH INTRANASAL LIVE ATTENUATED INFLUENZA VACCINE (LAIV) IN GERMANY

被引：0
|
作者：
Damm, O. [1 ]
Rose, M. A. [2 ]
Greiner, W. [3 ]
Knuf, M. [4 ]
Wahn, U. [5 ]
Krueger, H. [6 ]
Wutzler, P. [7 ]
Schaberg, T. [8 ]
Ruf, B. [9 ]
Liese, J. G. [10 ]
Eichner, M. [11 ]
机构：
[1] Univ Bielefeld, Sch Publ Hlth, D-33615 Bielefeld, Germany
[2] Goethe Univ Frankfurt, Childrens & Adolescents Hosp, Frankfurt, Germany
[3] Herescon GmbH, Hannover, Germany
[4] Childrens Hosp, Dr Horst Schmidt Klin, Wiesbaden, Germany
[5] Charite, Childrens Hosp, D-13353 Berlin, Germany
[6] AstraZeneca GmbH, Wedel, Germany
[7] Univ Jena, Jena Univ Hosp, Jena, Germany
[8] Deakoness Hosp, Rotenburg, Germany
[9] Klinikum St Georg, Leipzig, Germany
[10] Univ Childrens Hosp, Wurzburg, Germany
[11] Epimos GeoInfoNet UG, Tubingen, Germany
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.266
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A280 / A280
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
    Tarride, Jean-Eric
    Burke, Natasha
    Von Keyserlingk, Camilla
    O'Reilly, Daria
    Xie, Feng
    Goeree, Ron
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2012, 4 : 287 - 298
  • [2] Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review
    Chan, Kenneth Sik-Kwan
    Wong, Charlene Hoi-Lam
    Choi, Horace Cheuk-Wai
    [J]. VACCINES, 2022, 10 (09)
  • [3] Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
    Oliver Damm
    Martin Eichner
    Markus Andreas Rose
    Markus Knuf
    Peter Wutzler
    Johannes Günter Liese
    Hagen Krüger
    Wolfgang Greiner
    [J]. The European Journal of Health Economics, 2015, 16 : 471 - 488
  • [4] Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
    Damm, Oliver
    Eichner, Martin
    Rose, Markus Andreas
    Knuf, Markus
    Wutzler, Peter
    Liese, Johannes Guenter
    Krueger, Hagen
    Greiner, Wolfgang
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (05): : 471 - 488
  • [5] INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS
    Tarride, J. E.
    Burke, N.
    von Keyserlingk, C.
    O'Reilly, D.
    Xie, F.
    Goeree, R.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A119 - A120
  • [6] Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States
    Caspard, Herve
    Gaglani, Manjusha
    Clipper, Lydia
    Belongia, Edward A.
    McLean, Huong Q.
    Griffin, Marie R.
    Talbot, H. Keipp
    Poehling, Katherine A.
    Peters, Timothy R.
    Veney, Naomi
    Ambrose, Christopher S.
    [J]. VACCINE, 2016, 34 (01) : 77 - 82
  • [7] An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years
    Ambrose, Christopher S.
    Yi, Tingting
    Falloon, Judith
    [J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2011, 5 (06) : 389 - 397
  • [8] An Integrated, Multistudy Analysis of the Safety of Ann Arbor Strain Live Attenuated Influenza Vaccine in Children Aged 2-17 Years
    C S Ambrose
    T Yi
    R Pilsudski
    J Falloon
    [J]. Pediatric Research, 2011, 70 : 479 - 479
  • [9] AN INTEGRATED, MULTISTUDY ANALYSIS OF THE SAFETY OF ANN ARBOR STRAIN LIVE ATTENUATED INFLUENZA VACCINE IN CHILDREN AGED 2-17 YEARS
    Ambrose, C. S.
    Yi, T.
    Pilsudski, R.
    Falloon, J.
    [J]. PEDIATRIC RESEARCH, 2011, 70 : 479 - 479
  • [10] EFFICACY OF LIVE ATTENUATED INFLUENZA VACCINE (LAIV) BY AGE IN CHILDREN 6 MONTHS TO 17 YEARS OF AGE
    Belshe, R.
    Toback, S.
    Moren, S.
    Ambrose, C.
    Yi, T.
    [J]. ACTA PAEDIATRICA, 2009, 98 : 86 - 86
12345